ALFONSO
GÓMEZ DE ITURRIAGA PIÑA
![Foto de ALFONSO](/img/nophoto.png)
![Foto de Hospital de Cruces](/img/noimage_org.png)
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Cruces (27)
2024
-
Criteria and indicators to evaluate quality of care in genitourinary tumour boards
Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1639-1646
-
Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities
Clinical and Translational Radiation Oncology, Vol. 45
2023
-
Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer
World Journal of Urology, Vol. 41, Núm. 12, pp. 3829-3838
2021
-
Extreme hypofractionation with sbrt in localized prostate cancer
Current Oncology, Vol. 28, Núm. 4, pp. 2933-2949
-
Salvage brachytherapy for locally recurrent prostate cancer after single-fraction 19 Gy high-dose-rate brachytherapy: Toxicity, prostatespecific antigen kinetics, and cancer control
Journal of Contemporary Brachytherapy, Vol. 13, Núm. 1, pp. 12-17
2020
-
Oligometastatic prostate adenocarcinoma. Clinical-pathologic study of a histologically under-recognized prostate cancer
Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-9
-
Pain response and quality of life assessment in patients with moderate/severe neuropathic pain due to bone metastasis undergoing treatment with palliative radiotherapy and tapentadol: A prospective multicentre pilot study
Journal of Medical Imaging and Radiation Oncology, Vol. 64, Núm. 6, pp. 859-865
-
Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group
European urology oncology, Vol. 3, Núm. 4, pp. 455-463
2019
-
Late toxicity after single dose HDR prostate brachytherapy and EBRT for localized prostate cancer: Clinical and dosimetric predictors in a prospective cohort study
Radiotherapy and Oncology, Vol. 135, pp. 13-18
-
Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes
Clinical and Translational Oncology, Vol. 21, Núm. 8, pp. 1044-1051
2018
-
Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database
Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 193-200
-
Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter?
Journal of Medical Imaging and Radiation Oncology, Vol. 62, Núm. 4, pp. 578-584
-
Detection and quantification of 223Ra uptake in bone metastases of patients with castration resistant prostate carcinoma, with the aim of determining the absorbed dose in the metastases
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 1, pp. 20-27
-
High-risk localized prostate cancer: How important is the addition of brachytherapy to external-beam radiotherapy?
Journal of Clinical Oncology
-
Short-term Toxicity of High Dose Rate Brachytherapy in Prostate Cancer Patients with Inflammatory Bowel Disease
Clinical Oncology, Vol. 30, Núm. 9, pp. 534-538
2017
-
Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma
Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1337-1349
-
Transperineal biopsies of MRI-detected aggressive index lesions in low- and intermediate-risk prostate cancer patients: Implications for treatment decision
Brachytherapy, Vol. 16, Núm. 1, pp. 201-206
2016
-
Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272]
Reports of Practical Oncology and Radiotherapy
-
Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trial
Radiotherapy and Oncology, Vol. 119, Núm. 1, pp. 91-96
-
Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy
Journal of Contemporary Brachytherapy, Vol. 8, Núm. 6, pp. 477-483